Sage Therapeutics, Inc. Operating Cash Flow
Sage Therapeutics, Inc. reported Operating Cash Flow of -$140.42 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-07-30
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$58.69M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$81.73M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$66.56M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$82.36M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$267.19M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$540.59M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$460.04M.
- Sage Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$378.18M, a 156.93% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$58.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$140.42M 10-Q · filed 2025-07-30 | -$206.98M derived: sum of 3 quarters · filed 2025-07-30 | -$289.34M derived: sum of 4 quarters · filed 2025-07-30 |
| 2025-03-31 | -$81.73M 10-Q · filed 2025-04-29 | -$148.29M derived: sum of 2 quarters · filed 2025-04-29 | -$230.65M derived: sum of 3 quarters · filed 2025-04-29 | -$311.09M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-12-31 | -$66.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$148.93M derived: sum of 2 quarters · filed 2025-02-11 | -$229.36M derived: sum of 3 quarters · filed 2025-07-30 | -$267.19M 10-K · filed 2025-02-11 |
| 2024-09-30 | -$82.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$162.80M derived: sum of 2 quarters · filed 2025-07-30 | -$200.63M 10-Q · filed 2024-10-29 | -$320.15M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-06-30 | -$80.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$118.27M 10-Q · filed 2025-07-30 | -$237.79M derived: sum of 3 quarters · filed 2025-07-30 | -$373.65M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | -$37.83M 10-Q · filed 2025-04-29 | -$157.35M derived: sum of 2 quarters · filed 2025-04-29 | -$293.22M derived: sum of 3 quarters · filed 2025-04-29 | -$424.74M derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | -$119.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$255.38M derived: sum of 2 quarters · filed 2025-02-11 | -$386.90M derived: sum of 3 quarters · filed 2025-02-11 | -$540.59M 10-K · filed 2025-02-11 |
| 2023-09-30 | -$135.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$267.38M derived: sum of 2 quarters · filed 2024-10-29 | -$421.07M 10-Q · filed 2024-10-29 | -$548.00M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$131.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$285.20M 10-Q · filed 2024-07-31 | -$412.13M derived: sum of 3 quarters · filed 2025-02-11 | -$531.00M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$153.68M 10-Q · filed 2024-04-25 | -$280.61M derived: sum of 2 quarters · filed 2025-02-11 | -$399.48M derived: sum of 3 quarters · filed 2025-02-11 | -$505.92M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$126.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$245.80M derived: sum of 2 quarters · filed 2025-02-11 | -$352.24M derived: sum of 3 quarters · filed 2025-02-11 | -$460.04M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$118.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$225.30M derived: sum of 2 quarters · filed 2023-11-07 | -$333.10M 10-Q · filed 2023-11-07 | -$430.61M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$106.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$214.24M 10-Q · filed 2023-08-07 | -$311.74M derived: sum of 3 quarters · filed 2024-02-14 | -$380.57M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$107.80M 10-Q · filed 2023-05-02 | -$205.30M derived: sum of 2 quarters · filed 2024-02-14 | -$274.13M derived: sum of 3 quarters · filed 2024-02-14 | -$376.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$97.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$166.33M derived: sum of 2 quarters · filed 2024-02-14 | -$269.10M derived: sum of 3 quarters · filed 2024-02-14 | -$378.18M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$68.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$171.59M derived: sum of 2 quarters · filed 2022-11-08 | -$280.68M 10-Q · filed 2022-11-08 | $730.29M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$102.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$211.85M 10-Q · filed 2022-08-02 | $799.12M derived: sum of 3 quarters · filed 2023-02-16 | $708.10M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$109.09M 10-Q · filed 2022-05-03 | $901.88M derived: sum of 2 quarters · filed 2023-02-16 | $810.87M derived: sum of 3 quarters · filed 2023-02-16 | $691.88M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $919.96M derived: sum of 2 quarters · filed 2023-02-16 | $800.97M derived: sum of 3 quarters · filed 2023-02-16 | $664.28M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$91.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$210.00M derived: sum of 2 quarters · filed 2021-11-02 | -$346.69M 10-Q · filed 2021-11-02 | -$463.42M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$118.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$255.68M 10-Q · filed 2021-08-03 | -$372.40M derived: sum of 3 quarters · filed 2022-02-24 | -$501.10M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$136.69M 10-Q · filed 2021-05-04 | -$253.42M derived: sum of 2 quarters · filed 2022-02-24 | -$382.12M derived: sum of 3 quarters · filed 2022-02-24 | -$515.46M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$116.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$245.43M derived: sum of 2 quarters · filed 2022-02-24 | -$378.77M derived: sum of 3 quarters · filed 2022-02-24 | -$528.71M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$128.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$262.05M derived: sum of 2 quarters · filed 2020-11-05 | -$411.98M 10-Q · filed 2020-11-05 | -$513.76M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$133.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$283.28M 10-Q · filed 2020-08-10 | -$385.06M derived: sum of 3 quarters · filed 2021-02-24 | -$465.24M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$149.93M 10-Q · filed 2020-05-07 | -$251.71M derived: sum of 2 quarters · filed 2021-02-24 | -$331.90M derived: sum of 3 quarters · filed 2021-02-24 | -$332.03M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$101.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$181.97M derived: sum of 2 quarters · filed 2021-02-24 | -$182.10M derived: sum of 3 quarters · filed 2021-02-24 | -$260.67M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$80.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$80.32M derived: sum of 2 quarters · filed 2019-11-12 | -$158.89M 10-Q · filed 2019-11-12 | -$217.79M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$78.71M 10-Q · filed 2019-08-06 | -$137.60M derived: sum of 3 quarters · filed 2020-02-27 | -$183.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$78.57M 10-Q · filed 2019-05-02 | -$137.47M derived: sum of 2 quarters · filed 2020-02-27 | -$183.56M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$58.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$104.99M derived: sum of 2 quarters · filed 2020-02-27 | -$219.28M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$46.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$160.38M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$114.29M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | -$118.68M 10-K · filed 2019-02-19 |